WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

C CARDIOVASCULAR SYSTEM

This group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.


C07 BETA BLOCKING AGENTS
C07A BETA BLOCKING AGENTS

All plain beta blocking agents are classified in this group.
Labetalol, and carvedilol are classified in C07AG - Alpha- and beta blocking agents.
Beta blocking agents in combination with ACE inhibitors are classified in C09BX - ACE inhibitors, other combinations.
Beta blocking agents in combination with ARBs are classified in C09DX - Angiotensin II receptor blockers (ARBs), other combinations.

The DDDs are based on the treatment of mild-moderate hypertension.
The DDDs for oral and parenteral formulations are equal, even if the parenteral preparations are used for the initial treatment of arrhythmias. Exception: practolol.


C07AB Beta blocking agents, selective

All plain selective beta blocking agents are classified in this group.
The s-enantiomer and the racemate of atenolol are classified at separate 5th levels.

Different DDDs have been assigned for the two stereoisomeric forms of atenolol due to different potency.


    ATC code  Name  DDD  U Adm.R Note
    C07AB09 esmolol 2.5 

List of abbreviations

Last updated: 2024-01-26